We describe a case of pacemaker endocarditis due to Candida albicans in a patient who responded favorably to combined surgical and antifungal therapy. Only five cases of candidal pacemaker endocarditis have been reported previously. We review these five cases and discuss the clinical presentation and therapy for this disease in comparison with candidal prosthetic valve endocarditis.
The first case of candidal endocarditis that developed in Pristinamycin therapy was replaced with parenteral antibiotic association with a permanently implanted pacemaker was retherapy with vancomycin, ceftazidime, and amikacin, and the ported in 1969 by Davis et al. [1] . We report a case in which patient was also treated with heparin. His condition improved a patient with pacemaker endocarditis due to Candida albicans clinically, although an elevated temperature of 38ЊC (which was cured after removal of the pacemaker wires in combination was attributed to the venous toxic effect of vancomycin) was with antifungal therapy. In reviewing the literature published noted. After 2 weeks, therapy was switched to oral fusidic between 1969 and 1997, we identified only five cases of canacid and cefixime. Surgical removal of intracavitary wires was didal pacemaker endocarditis. Early diagnosis and aggressive performed. On 21 July 1995, the patient underwent right atrioappropriate therapy are needed for a favorable outcome.
tomy, and a vegetation (1 cm in diameter) adjacent to the septum auricularum was found. The vegetation, the three wires, and the pacemaker were removed. Cultures of the vegetation and the wires were all positive Case Report for C. albicans. Furthermore, coagulase-positive staphylococci A 56-year-old man with a medical history that was unrewere isolated from one intracavitary wire, and C. albicans was markable except for chronic obstructive bronchitis had received recovered from the right femoral catheter that had been inserted a pacemaker in 1991 because of symptomatic sinusal dysfunca few days earlier and removed at the time of surgery. Two tion. In March 1995, infection of the pacemaker pouch led to cultures of blood obtained 2 days before surgery yielded ablation of the pacemaker; a new one with a ventricular pacer C. albicans, and the patient was transferred to our institution lead was implanted in a contralateral site, without the removal for management of antifungal therapy. of existing intracavitary wires. No pathogen was isolated from Laboratory analyses showed the following values: neutrophil pus. On 20 June 1995, the patient became febrile, and oral count, 10,640/mm 3 ; erythrocyte sedimentation rate (ESR), 82 antibiotic therapy with pristinamycin was initiated. He was mm/h; and C-reactive protein level, 104 mg/L. Antibodies to admitted to the hospital on 3 July 1995 because of dyspnea Candida were demonstrated by hemagglutination (titer, 2,560) and fever that persisted during pristinamycin therapy. and counterimmunoelectrophoresis (six arcs). As of 25 July Physical examination detected left basilar crackles without 1995, the patient began receiving treatment with amphotericin congestive heart failure. In our case, the generator pocket could have been the initial endocarditis are discussed below and compared with those of site of infection, since 3 months before the onset of endocardipacemaker infections due to other microorganisms and those tis, the patient had a collection in the pacemaker pouch that of candidal infections of other intravascular devices.
remained culture negative and led to the removal of the generaPermanent pacemaker placement is a common practice. Intor but not the pacing electrodes. However, we cannot exclude fections of pacemaker systems have been described in 1% -the possibility that his initial fever was related to staphylococcal 7% of patients [2 -4] . Pacemaker endocarditis is characterized infection and that Candida was an opportunistic pathogen as by an infected focus located on the pacemaker electrode tip, a result of the selection effect of a prolonged course of antibacthe tricuspid valve, or fibrotic endocardial areas in contact terial therapy. The femoral catheter could have possibly been with the electrode tip; endocarditis represents about 10% of the portal of entry for candidemia. Fungemia persisted 6 days pacemaker infections [5] . The literature on transvenous paceafter surgery, whereas Doppler ultrasonography showed right maker endocarditis consists mainly of individual case reports femoral thrombosis (which suggests that the thrombus was or small case series. Pacemaker endocarditis and early prosinfected). The intravascular catheter may have been the source thetic valve endocarditis have similar microbiological profiles; of fungemia or the target of hematogenous seeding from anthe most frequent pathogens are Staphylococcus aureus and other site. Whatever the mechanism involved in fungal infecStaphylococcus epidermidis [6] . In a large series of 44 patients tion, C. albicans -positive cultures of specimens from all sites, [5] , echocardiography was diagnostic or suggestive of endocarincluding the vegetation, established the diagnosis of fungal ditis in 54% of the patients, but this low percentage may reflect endocarditis. the infrequent usage of transesophageal echocardiography Candidal pacemaker endocarditis (which is a right-sided in-(which might be of value in the diagnosis of this infection). fection) should be considered a form of fungal prosthetic valve We used MEDLINE to search the literature for cases of endocarditis even though most cases of prosthetic valve endocandidal pacemaker endocarditis reported from 1971 to 1996; carditis are left-sided (table 2) . Ten percent of all cases of the key words were pacemaker, infection, Candida, and endoprosthetic valve endocarditis are due to Candida species. The carditis. We found only five cases (table 1). The first case of risk factors for candidal prosthetic valve endocarditis are cenright-sided candidal endocarditis that developed in association tral venous catheters, prior therapy with antibacterial agents, with a permanently implanted transvenous pacemaker was reand recent cardiothoracic surgery; these risk factors should also ported in 1969 [1] . The diagnosis was made at autopsy on the be considered as risk factors for candidal pacemaker endocardibasis of the presence of a large candidal vegetation that was tis. C. albicans is the most common fungal pathogen involved attached to the right atrial wall and partially obstructed the in prosthetic valve endocarditis [11] . tricuspid valve. Two other cases due to Candida were reported
In a recent review of 18 cases of candidal prosthetic valve by Arber et al. [5] in a large series of 44 cases of pacemaker endocarditis [12] , infection was always left-sided. Sixty-seven endocarditis that were identified from 1982 to 1992; features percent of the patients presented with the sudden onset of of these two subjects were only partially detailed.
symptoms, and blood cultures were positive for all patients. As shown in table 1, the delay between pacemaker placement
The mortality rate was 54%. The incidence of embolization in and diagnosis of candidal endocarditis varies widely (from õ2 cases of fungal prosthetic valve endocarditis has been reported months to 8 years). C. albicans was identified in four of the to range from 41% to 70% [13] . Our case had several features in common with cases of candidal prosthetic valve endocarditis, five cases. In addition, at least three cases of pacemaker pocket / 9c40$$de04
11-03-97 20:01:32 cidas UC: CID including positive blood cultures, an embolus during the course Amphotericin B is the drug of choice, at least during the initial phase of therapy. We have shown that amphotericin of the disease, and a large-sized vegetation. The association of persistent fever, a vegetation on a foreign body, and previous B is clearly more effective than fluconazole as treatment of experimental left-sided C. albicans endocarditis [21] . In the embolization prompted us to remove all the wires. present case, we used the combination of amphotericin B and Management pacemaker-associated endocarditis due to bac-5-fluorocytosine, which has been shown to be more effective teria remains controversial because of a lack of prospective than amphotericin B alone as treatment for infections due to studies comparing medical treatment with the combination of Cryptococcus [22] as well as Candida [23, 24] . Successful intensive antibiotic therapy and electrode removal. Leaving therapy with antifungal agents alone has been reported in some wires in the setting of infection may favor the failure of antibicases of candidal prosthetic valve endocarditis [25, 26] (providotic therapy. On the other hand, removing the electrode is not ing that the drugs could be administered for a prolonged pealways simple: intravenous traction done by an interventional riod), but these results must be confirmed. Furthermore, relapse cardiologist may be associated with complications such as a may occur late after the end of therapy. In our case, the decision tear of the tricuspid valve, and removal by cardiotomy is associto remove intravascular wires on the basis of persistent fever ated with morbidity and mortality. When the results of the allowed us to control the infection rapidly and easily. different reported studies were pooled [5] , there was a signifi-
In conclusion, candidal pacemaker endocarditis remains rare. cant advantage of combined surgery and medical treatment This disease shares with candidal prosthetic valve endocarditis over medical treatment alone. That analysis did not specify features that should help in its diagnosis. As in other candidal whether the nature of the pathogen affects the absolute need intravascular device infections, early aggressive combined surgifor electrode removal. The severity of candidemia in the prescal and medical therapy is advocated. This infection may repreence of intravascular devices results from the properties of the sent one of the most severe forms of pacemaker endocarditis. Candida species. Candida species can adhere to various plastics, which favors their colonization of foreign intravascular and, in particular, intracardiac materials. C. albicans mediates 
